🔎 Trials Near Me

Utama › Penyakit Paru Interstisial › New York

Kajian klinikal Penyakit Paru Interstisial di New York

20 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • Weill Cornell Medicine-New York-60569, New York
  • Columbia University Medical Center-New York Presbyterian Hospital, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • Weill Cornell Medicine-New York-60569, New York
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA005, New York
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07179380

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • NYU Langone Health, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Weill Cornell Medicine, New York
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05798923

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), East White Plains
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07323732

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • Icahn School of Medicine at Mount Sinai, New York
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • University of Buffalo, Buffalo
  • Weill Cornell University Medical College, New York
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • NYU Langone Health, New York
  • University of Rochester Medical Center, Rochester
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Northwell Health, New Hyde Park
  • New York University Langone Medical Center, New York
  • New York Presbyterian Hospital - Weill Cornell Medicine, New York
  • dan 1 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06388421

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  • Weill Cornell Medicine, New York
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 80 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06855329

Platform Clinical Study for Conquering Scleroderma

  • Northwell Health, Great Neck
  • Hospital for Special Surgery, New York
  • Columbia University Medical Center, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Columbia University Irving Medical Center, New York
  • University of Rochester, Rochester
Mengambil pesertaFasa 2/3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06328777

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • Weill Medical College of Cornell University, New York
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

  • University of Rochester Medical Center, Rochester
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jul 2026 · NCT07561034

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Northwell Health, New Hyde Park
  • Weill Cornell Medicine, New York-Presbyterian Hospital, New York
  • Stony Brook Advanced Specialty Care, Stony Brook
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05943535

Cough Capture as a Portal Into the Lung

  • Albert Einstein College of Medicine, The Bronx
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 13 Jan 2026 · NCT05854563

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Mei 2025 · NCT05892614

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.